Variant Bio

About:

Variant Bio is leveraging the power of human genetic diversity to discover new therapeutics.

Website: https://www.variantbio.com/

Twitter/X: variantbio

Top Investors: Alexandria Venture Investments, General Catalyst, SoftBank Vision Fund, Lux Capital, Alta Partners

Description:

Variant Bio is leveraging the power of human genetic diversity to discover new therapeutics. The company's focus is to identify individuals and populations around the world who are extreme outliers for traits of medical relevance and to use innovative sequencing and analytic approaches to identify genes and pathways linked to these traits. Variant Bio was founded in 2018 and headquartered in Seattle, Washington.

Total Funding Amount:

$130M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Seattle, Washington, United States

Founded Date:

2018-01-01

Founders:

Kaja Wasik, Kaja Wasik, Stephane Castel

Number of Employees:

11-50

Last Funding Date:

2021-11-09

IPO Status:

Private

Industries:

© 2025 bioDAO.ai